Globe Life (GL) Investments and Cash — Quarterly & Annual

Screener

Discontinued — last reported Q4 '19

Investments and Cash at other companies

AflacAFL

$103B-7.8%

Segments

By segment

Investment$20.66B+2.1%

Health$0—

Life$0—

Other financials

Income statement

Revenue$1.6B+8.0%

Net income$287.7M+13.8%

EPS (diluted)$3.65+19.7%

Balance sheet

Cash & equivalents$255.2M+9.9%

Total debt$3.2B-1.3%

Total equity$6.1B+12.1%

Total assets$31.0B+4.2%

Cash flow

Operating cash flow$420.9M-2.5%

CapEx$24.9M+112%

Free cash flow$396.0M-5.7%

Valuation

Market cap$14.28B+22.5%

Enterprise value$17.26B-0.8%

P/E11.8×+0.8×

P/S2.3×+0.3×

Profitability

Net margin19.6%+1.5pp

FCF margin20.2%-3.9pp

Returns & leverage

Return on equity20.5%0.0pp

Debt / equity0.5×-0.1×

Where this comes from

Reported directly by Globe Life in its filing.

Tagged under the XBRL concept us-gaap:InvestmentsAndCash.

The source filing: Globe Life’s 10-K, filed February 27, 2020. Open the filing →

Filed: Feb 27, 2020, 4:12 PM EST
Fiscal year: FY2019
Accession: 0000320335-20-000008